Can PrEP stop HIV in west african men? new study says yes, it's feasible.

NCT ID NCT03459157

Completed Prevention Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether men who have sex with men (MSM) in Burkina Faso, Côte d'Ivoire, Mali, and Togo would accept and use PrEP (a daily or on-demand pill) to prevent HIV. Over 600 HIV-negative men at high risk took part, receiving regular check-ups, STI testing, and support. The goal was to see if PrEP is practical and effective in real-world community clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV/AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS Homosexuality HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV/AIDS

Contacts and locations

Locations

Centre Lucia, Espoir Vie Togo

Lomé, Togo
Centre Oasis, Association African Solidarité

Ouagadougou, Burkina Faso
Clinique de Confiance, Espace Confiance

Abidjan, Côte d’Ivoire
Clinique des Halles, ARCAD-SIDA

Bamako, Mali

More trials for these conditions

Other studies related to the condition(s) this trial covers.